Gene test could predict severe side effects in breast cancer patients
NCT ID NCT07582887
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study explores whether certain genetic variations can predict severe side effects from powerful breast cancer drugs called antibody-drug conjugates. Researchers will analyze blood samples from 70 patients with advanced breast cancer to see if a specific gene (UGT1A1) is linked to higher risks of diarrhea and low white blood cell counts. The goal is to use this information to personalize treatment and reduce harm.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Clínico San Cecilio
RECRUITINGGranada, Granada, 18016, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.